So the latest conspiracy theory is that the issue of the Phase 2 and 3 designation on the clinical trials website is somehow related to the recruitment of patients?
Not withstanding the fact that the CEO advised that when they updated the website with the additional trial sites, they encountered a technical problem (with the website) that caused an error in the trial designation section. He went on to say they were having it rectified and it would be fixed in 1 - 2 weeks. And of course, that is exactly what happened.
What pray tell has any of that got to do with the patient enrollment for CAN004?
So the latest conspiracy theory is that the issue of the Phase 2...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |